Take Your Trading To The Next Level. Get Started Here!
+1 (949) 514 8188
Moderna compared the flu vaccine, dubbed mRNA-1010, to a currently approved seasonal flu vaccine from GlaxoSmithKline called Fluarix.
Moderna says flu vaccine showed promising results in phase three trial, paving path to approval
Moderna compared the flu vaccine, dubbed mRNA-1010, to a currently approved seasonal flu vaccine from GlaxoSmithKline called Fluarix.
Archives
Categories
Archives
Recent Posts
Meta
Categories
Calender